Minireviews
Copyright ©The Author(s) 2021.
World J Hepatol. Sep 27, 2021; 13(9): 1042-1057
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1042
Figure 2
Figure 2 Proposed ideal candidates to for stopping the use of antiviral agents in chronic hepatitis B patients. EOT: End of treatment; HBcrAg: Hepatitis B core-related antigen; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.